for Diflunisal Tablets

About this update from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A

Announcement on Obtaining the “Notice of Approval for Drug Supplementary Application” for Diflunisal Tablets The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A